Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis Marta O. SoaresLuísa Canto e Castro Practical Application 23 December 2012 Pages: 1101 - 1117
Bevacizumab for Metastatic Colorectal Cancer Sophie WhyteAbdullah PandorMatt Stevenson Review Article 23 December 2012 Pages: 1119 - 1132
A Systematic Review and Critical Assessment of Health State Utilities Scott DoyleAndrew LloydAlastair Gray Systematic Review 23 December 2012 Pages: 1133 - 1143
Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis Cécile Gaujoux-VialaBruno Fautrel Systematic Review 23 December 2012 Pages: 1145 - 1156
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis Lanting LuHilary PearceKen Stein Original Research Article 23 December 2012 Pages: 1157 - 1171
Chemotherapy Administration Philip HaywoodJohan de RaadRobyn Ward Original Research Article 23 December 2012 Pages: 1173 - 1186
What’s Good and Bad About Contraceptive Products? Stephanie A. KnoxRosalie C. VineyDeborah Bateson Original Research Article 23 December 2012 Pages: 1187 - 1202
Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets Liv Ariane AugestadKim Rand-HendriksenKnut Stavem Original Research Article 23 December 2012 Pages: 1203 - 1214
